Education and Support Help Patients Better Follow HIV Treatment

Key points
- Practical advice and individualized attention can help people with HIV stick to a consistent drug regimen, according to a new review of studies.
- The studies were too different to combine results, but the review team found that the most successful programs emphasized "practical medicine management," one-on-one attention or a 12-week or longer duration.
- Today's powerful antiretroviral drug combinations work best when patients follow doctor's orders, but many patients struggle to adhere to a strict medication schedule.
- The review examined 19 studies that tested different patient education and support strategies.
Practical advice and individualized attention can help people with HIV stick to a consistent drug regimen, according to a new review of studies.
The studies were too different to combine results, but the review team found that the most successful programs emphasized "practical medicine management," one-on-one attention or a 12-week or longer duration.
Today's powerful antiretroviral drug combinations work best when patients follow doctor's orders, but many patients struggle to adhere to a strict medication schedule.
The review examined 19 studies that tested different patient education and support strategies.
"A one time visit probably is not going to do it. You need multiple visits over a period of time with someone who can talk to you about your individual needs," said, study author Richard Glazier, a family doctor at St. Michael's Hospital in Toronto.
He said practical medicine management was associated with better outcomes than strategies that took a psychological tack by providing cognitive behavior therapy or motivational interviews.
The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic.
Drug adherence is a problem in all of health care, Glazier said. . "It has to do with not remembering every day. The phenomenon is the same among people with diabetes, high blood pressure, cholesterol or HIV. People don't take all their doses because they are distracted, because they've run out of their medication, because they've been traveling," he said.
Poor drug compliance is not unique to HIV care. But the issue is complicated because HIV drug regimens can be complex and because inattentive dosing can curb a medicine's ability to suppress virus in the body.
A typical HIV drug cocktail includes at least three different medications and can include many pills taken at precise times throughout the day.
"These drugs are real lifesavers, but if you stop your medications and start them again, - and kind of do that repeatedly - the virus is very smart, and it can develop resistance," Glazier said.
Even brief periods of non-adherence can have lifelong implications. Once the body builds up resistance to a particular drug cocktail, it is no longer effective and doctors have to find another medication combination among the short list of available antiretroviral drugs.
While the consequences of non-adherence are severe in HIV care, Glazier said: "it's not a hopeless case. These interventions by and large have the potential to work, adherence is a huge problem, but a variety of different kinds of interventions have been shown to be helpful."
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsFungus deadly to AIDS patients found to grow on trees
Researchers have pinpointed the environmental source of fungal infections that have been sickening HIV/AIDS patients in Southern California for decades. It literally grows on trees. The discovery is based on the science…
22 August 2014
NewsDrug that reduces abdominal fat in HIV patients also may reduce fat in liver
The only drug to receive FDA approval for reduction of the abdominal fat deposits that develop in some patients receiving antiviral therapy for HIV infection may also reduce the incidence of fatty liver disease in such…
21 July 2014
NewsGrowth hormone analog may reduce risk of fatty liver disease in HIV-infected patients
In a preliminary study, HIV-infected patients with excess abdominal fat who received the growth hormone-releasing hormone analog tesamorelin for 6 months experienced modest reductions in liver fat, according to a study…

